NEW YORK, NY (Marketwire – Oct 28, 2011)
Prostate cancer expert, Dr. David Samadi, continues his dedication to improving medical care worldwide and increasing accessibility of medical technology by traveling to the Netherlands this week. During his stay, he will lend his prostate cancer knowledge and robotic surgery expertise to local specialists while performing live robotic prostatectomy procedures. Using his SMART (Samadi Modified Advanced Robotic Technique) Surgery, Dr. Samadi will remove the cancerous prostates of several patients.
As Vice Chairman, Department of Urology, and Chief of Robotics and Minimally Invasive Surgery at The Mount Sinai Medical Center, Dr. Samadi’s expertise in urology, prostate cancer, and robotic prostatectomy surgery is vast. He routinely travels overseas to educate doctors on his life-saving, minimally invasive robotic prostatectomy surgical techniques.
Dr. Samadi will partner with Dr. Jelle Barentsz, a specialist in MRI of Urogenital diseases and MR-contrast agents at The Dutch Radboud University Nijmegen Medical Center in the Netherlands where the procedures will take place. The MR imaging used by Dr. Barentsz allows him to detect prostate cancer early and identify its exact location and aggressiveness. Further, he believes its microscopic clarity will be an important addition to Dr. Samadi’s technique during surgery. “The combination of our accurate MRI prostate cancer staging and Dr. Samadi’s precise robotic surgery will be a highly successful equation for our patients. We welcome his expertise and look forward to applying his SMART procedure in the future,” said Dr. Barentsz.
A solid foundation in both open, traditional surgery and robotic surgery come together in Dr. Samadi’s unique approach to prostatectomy. Few surgeons in the United States have successfully united the principals of laparoscopy and robotic surgery with urologic oncology the way Dr. Samadi has. In his more than 7,000 successful robotic prostatectomy procedures, Dr. Samadi has delivered superior results in prostate cancer cure, urinary continence and sexual potency. “Success in robotic surgery comes from experience. I look forward to sharing my experiences with Dr. Barentsz and his colleagues and helping them deliver patient success,” said Dr. Samadi.
Beyond experience, Dr. Samadi alsoattributes his success to technique. “During surgery I am able to control the length of the urethra by not suturing the dorsal vein complex. The longer the urethra, the better the continence results,” Dr. Samadi explains. Reduced blood loss during surgery, shorter hospital stay and faster recovery are also among the benefits of robotic prostatectomy surgery.
Like in the U.S., PSA screening has undergone scrutiny in the Netherlands but both Drs. Samadi and Barentsz share the belief that early detection of prostate cancer is the key to saving lives.
While in the Netherlands, Dr. Samadi will perform multiple, live robotic prostatectomy surgeries as a means of training surgeons there. “Dr. Samadi’s teachings here in the Netherlands will begin a new era in our fight against prostate cancer,” said Dr. Barentsz.Press Release